Skip to content
Disclosery

Daventry Group, LP: HCAT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Daventry Group, LP on HCAT, newest first. How the timeline and the estimate are built.

Daventry Group, LP held 0 HCAT shares at 2025-03-31 per its 13F-HR filed 2025-05-15.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -2,509,480 shares

    13F-HR 0001892688-25-000121 filed by Daventry Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-12-31
    13F 2,509,480 shares
    Change vs previous 13F +91,878 shares

    6.78% of the 13F portfolio, value $17,742,024.

    13F-HR 0001172661-25-000856 filed by Daventry Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 2,417,602 shares
    Change vs previous 13F not available

    7.83% of the 13F portfolio, value $19,679,280.

    13F-HR 0001172661-24-004718 filed by Daventry Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).